Abstract
Background Once thought to be a passive process, the resolution of inflammation is now shown to involve active biochemical programmes controlled by endogenous anti-inflammatory and pro-resolution mediators, such as lipoxins and resolvias.Purpose The anti-inflammatory and pro-resolution mediators and cellular mechanisms of inflammation resolution have become increasingly well characterized. So, it is important to know about the present status and probable future trends of inflammation resolution. Content This review presents an update and overview of new cellular and molecular mechanisms for the resolution of inflammation, revealing key roles for lipoxins, cyclopentenone prostaglandins and recently discovered families of endogenous mediators, termed resolvins and protectins. These mediators have anti-inflammatory and pro-resolution properties, thereby suppressing pro-inflammatory gene expression and cell trafficking, inducing inflammatory-cell apoptosis and phagocytosis. Trend Developing drugs based on endogenous mediators and mechanisms that are inherent to resolution might represent a new strategy in antiinflammatory therapy. It is thought that this strategy will open up new avenues for the future management of inflammation-based diseases. Key words: Lipid mediator; Inflammation resolution; Lipoxin
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Anesthesiology and Resuscitation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
